DPPA3P1: A Potential Drug Target and Biomarker for Developmental Pluripotency

Target Name: DPPA3P1

NCBI ID: G728493

DPPA3P1

Other Name(s): Developmental pluripotency associated 3 pseudogene 1 | DPPA3 pseudogene 1

DPPA3P1: A Potential Drug Target and Biomarker for Developmental Pluripotency

Developmental pluripotency is a phenomenon of rapidly dividing cells that can give rise to a variety of cell types with unique functions. This process is essential for the development, repair, and regeneration of tissues in the body. One of the key genes involved in developmental pluripotency is DPPA3P1.

DPPA3P1 is a pseudogene that has been identified in many organisms, including humans. It is a member of the Pseudogene family, which are genes that have been preserved from ancient organisms but are still functional in the present day. The gene is expressed in many different tissues and cells, including stem cells, neural cells, and epithelial cells.

DPPA3P1 is involved in the development and maintenance of developmental pluripotency. It is a key regulator of the pluripotency gene, which encodes the master stem cell that can give rise to all cell types in the body. In addition, DPPA3P1 is involved in the regulation of cell proliferation and apoptosis, which are critical processes for the maintenance of tissue homeostasis and the development of complex tissues.

As a potential drug target, DPPA3P1 is an attractive target for researchers because it is involved in the development and maintenance of developmental pluripotency. This makes it an attractive target for drugs that are aimed at promoting or enhancing pluripotency, such as drugs that are used to treat cancer or diseases that involve tissue damage. In addition, DPPA3P1 is also a potential biomarker for many diseases, including cancer, because it is often expressed at higher levels in tissues that are affected by these diseases.

The biology of DPPA3P1

DPPA3P1 is a member of the Pseudogene family and has been identified in many different organisms, including humans. It is a small gene that is expressed in many different tissues and cells, including stem cells, neural cells, and epithelial cells. The gene is conserved across many different species, which suggests that it has an important role in the development and maintenance of biological diversity.

DPPA3P1 is involved in the development and maintenance of developmental pluripotency. It is a key regulator of the pluripotency gene, which encodes the master stem cell that can give rise to all cell types in the body. The pluripotency gene is a highly conserved gene that is involved in the development and maintenance of stem cells. It is expressed in many different tissues and cells, including the brain, spinal cord, and heart, and is involved in the development and maintenance of neural stem cells.

DPPA3P1 is also involved in the regulation of cell proliferation and apoptosis, which are critical processes for the maintenance of tissue homeostasis and the development of complex tissues. It is a negative regulator of the p53 gene, which is involved in the regulation of apoptosis. The p53 gene is a well-known gene that is involved in the regulation of apoptosis, which is the process by which cells undergo programmed cell death.

In addition, DPPA3P1 is involved in the regulation of cell adhesion, which is a critical process for the development and maintenance of tissues. It is a negative regulator of the E-cadherin gene, which is involved in the regulation of cell adhesion. E-cadherin is a transmembrane protein that is involved in the regulation of cell adhesion, and its dysfunction has been implicated in many diseases, including cancer.

Molecular biology of DPPA3P1

DPPA3P1 is a small gene that is expressed in many different tissues and cells. It is a member of the Pseudogene family and has been identified in many different organisms, including humans. The gene is conserved across many different species and is highly conserved within the same species.

The DPPA3P1 gene is

Protein Name: DPPA3 Pseudogene 1

The "DPPA3P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DPPA3P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets